Table 5.
The intersection of the total-stage liver cancer with our previous result.
| Protein | CRV (in this study) |
p value (in this study) |
CRV (previous) |
p value (previous) |
|---|---|---|---|---|
| BUB1B | 7.58 | 0.005833 | 5.5696 | 0.00064 |
| CDC20 | 11.28 | 0.002011 | 5.1507 | 0.00109 |
| CDK2 | 6.9 | 0.007708 | 14.069 | <1E − 5 |
| CUL3 | 8.16 | 0.004478 | 12.9519 | <1E − 5 |
| E2F1 | 10.19 | 0.002497 | 3.9947 | 0.00862 |
| ESR1 | 23.79 | 0.000652 | 10.3758 | <1E − 5 |
| HDAC4 | 10.11 | 0.002531 | 5.8397 | 0.00048 |
| HGS | 15.2 | 0.001329 | 4.6929 | 0.00232 |
| MYC | 7.55 | 0.005884 | 10.7821 | <1E − 5 |
| PCNA | 13.58 | 0.001572 | 15.1438 | <1E − 5 |
| PRKDC | 8.19 | 0.004418 | 5.9369 | 0.00041 |
| SMARCA4 | 13.21 | 0.001611 | 7.7449 | 0.0001 |
| SUMO1 | 10.36 | 0.002373 | 15.8533 | <1E − 5 |
| TRAF2 | 14.28 | 0.001461 | 4.7703 | 0.00207 |
| UBC | 25.19 | 0.000588 | 137.284 | <1E − 5 |